Items where authors include "Osborne, R."

Article

Abani, O., Abbas, A., Abbas, F. et al. (7724 more authors) (2025) Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Group, F.C., Glasbey, J., Beggs, A. et al. (430 more authors) (2024) Risk of Bowel Obstruction in Patients Undergoing Neoadjuvant Chemotherapy for High-risk Colon Cancer. Annals of Surgery, 280 (2). pp. 283-293. ISSN 0003-4932

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Dave, R.V. orcid.org/0000-0001-6827-8090, Barrett, E., Morgan, J. orcid.org/0000-0002-5337-5581 et al. (86 more authors) (2022) Wire- and magnetic-seed-guided localization of impalpable breast lesions: iBRA-NET localisation study. British Journal of Surgery, 109 (3). pp. 274-282. ISSN 0007-1323

Baird, R., Banks, I., Cameron, D. et al. (53 more authors) (2016) An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients. Ecancermedicalscience, 10. p. 608.

Vasey, P.A., Atkinson, R., Osborne, R. et al. (8 more authors) (2006) SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel gemcitabine as first-line chemotherapy for ovarian cancer. British Journal of Cancer, 94 (1). pp. 62-68. ISSN 0007-0920

Thompson, P., Wilson, P., Osborne, R. et al. (9 more authors) (1991) The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study. British Journal of Cancer, 64 (5). pp. 973-974. ISSN 0007-0920

Proceedings Paper

Kalantzis, N., Fletcher, T., Ahmedov, A. et al. (5 more authors) (2020) Co-simulation methods for holistic vehicle design : a comparison. In: SAE Technical Paper. WCX SAE World Congress Experience, 21-23 Apr 2020, Virtual conference. Society of Automotive Engineers (SAE International) .